Article

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

2022-03-04

Abstract excerpt

<h4>Summary</h4> Cancer heterogeneity at the proteome level may explain differences in therapy response and prognosis beyond the currently established genomic and transcriptomic based diagnostics. The relevance of proteomics for disease classifications remains to be established in clinically heterogeneous cancer entities such as chronic lymphocytic leukemia (CLL). Here, we characterized the proteome and transcrip...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e8cdfbd-1473-5652-b9bf-86a6a7889302
DOI: 10.1101/2022.03.01.481539

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaDOI 10.1101/2022.03.01.481539Read

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.Semantic proximity Read

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets.Semantic proximity Read

Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome DysregulationSemantic proximity Read

The protein landscape of chronic lymphocytic leukemia.Semantic proximity Read

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.Semantic proximity Read

Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.Semantic proximity Read

Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia.Semantic proximity Read

RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences.Semantic proximity Read

High-throughput proteomics identifies THEMIS2 as independent biomarker of treatment-free survival in untreated CLLSemantic proximity Read

Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells.Semantic proximity Read

Molecular map of chronic lymphocytic leukemia and its impact on outcome.Semantic proximity Read

Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia.Semantic proximity Read